BioSpace News Archive

Business

Q’STRAINT/Sure-Lok Announces the Winner of its Inaugural Q’MANITARIAN Award

Q’STRAINT/Sure-Lok is pleased to announce that Dan Allison, a highly acclaimed Occupational Therapist and Driving Specialist at the Shepherd Center, which U.S. News and World Report ranks among the top 10 rehabilitation hospitals in the nation, won the company’s inaugural Q’MANITARIAN Award.

November 4, 2019
·
2 min read
Business

Neurocrine Biosciences Reports Third Quarter 2019 Financial Results

Neurocrine Biosciences, Inc. announced its financial results for the quarter ended September 30, 2019 and provided an update on the launch of INGREZZA® and its clinical development programs..

November 4, 2019
·
16 min read
Business

Sierra Oncology Reports Third Quarter 2019 Results

MOMENTUM Phase 3 myelofibrosis clinical trial anticipated to launch in Q4 2019

November 4, 2019
·
11 min read
Biotech Beach

NuVasive to Present at the 28th Annual Credit Suisse Healthcare Conference

NuVasive, Inc. announced that management will present at the 28th Annual Credit Suisse Healthcare Conference at The Phoenician in Scottsdale, Arizona on Tuesday, November 12, 2019, at 1:50 p.m. MST/ 3:50 p.m. EST.

November 4, 2019
·
2 min read
Deals

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) on November 1, 2019

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to seven new employees.

November 4, 2019
·
2 min read
Business

Intrexon to Announce Third Quarter Financial Results on November 12th

Intrexon’s subsidiary Precigen to host conference call to provide business and pipeline updates

November 4, 2019
·
3 min read
Business

CTI BioPharma Reports Third Quarter 2019 Financial Results

CTI BioPharma Corp. reported its financial results for the third quarter and nine months ended September 30, 2019.

November 4, 2019
·
8 min read
Business

DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs

DURECT Corporation announced financial results for the three months ended September 30, 2019 and provided a corporate update.

November 4, 2019
·
15 min read
Drug Development

Revance Completes Enrollment in ASPEN-1 Phase 3 Pivotal Trial for Cervical Dystonia

DaxibotulinumtoxinA for Injection (DAXI) has potential to be first long-acting neuromodulator for treatment of this debilitating involuntary muscle movement disorder

November 4, 2019
·
8 min read
Business

Acorda Provides Update for Third Quarter Ended September 30, 2019

Acorda Therapeutics, Inc. provided a financial update for the quarter ended September 30, 2019..

November 4, 2019
·
15 min read